Glycogen synthase kinase-3 and alternative splicing.

Area of Science:

• Molecular Biology
• RNA Biology
• Cancer Biology

Background:

• Glycogen synthase kinase-3 (GSK-3) is a key regulator of multiple signaling pathways, including receptor tyrosine kinase, cytokine, and Wnt.
• GSK-3 influences diverse cellular processes such as transcription, nutrient sensing, and cell fate.
• Recent studies highlight GSK-3's role in regulating alternative splicing and RNA processing.

Purpose of the Study:

• To investigate the role of GSK-3 in mRNA processing and alternative splicing.
• To explore the implications of GSK-3-dependent RNA processing in normal and malignant hematopoiesis.

Main Methods:

• Phosphoproteomic analysis to identify GSK-3-dependent phosphorylation sites on splicing factors.
• Analysis of mRNA splicing changes upon GSK-3 inhibition.
• Examination of Gsk3 loss in mouse models of hematopoiesis.

Main Results:

• GSK-3 directly phosphorylates multiple splicing factors and RNA biosynthesis regulators.
• Inhibition of GSK-3 leads to widespread alterations in mRNA splicing.
• GSK-3-regulated proteins are frequently mutated in leukemia and myelodysplasia.
• Loss of Gsk3 in hematopoietic cells results in myelodysplastic neoplasms in mice.

Conclusions:

• GSK-3 is a critical regulator of mRNA processing and alternative splicing.
• Dysregulation of GSK-3 in RNA processing contributes to hematological malignancies.
• Targeting GSK-3 may offer therapeutic strategies for leukemia and myelodysplastic syndromes.